{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:03:48Z","timestamp":1769753028589,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,29]]},"DOI":"10.7759\/cureus.85017","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T10:27:12Z","timestamp":1748514432000},"source":"Crossref","is-referenced-by-count":1,"title":["Assessing the Knowledge of Diabetic Patients About Glucagon Use in Hypoglycemia: A Cross-Sectional Study in Riyadh, Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Adel","family":"Hussien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alhasan M","family":"Alkharasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid A","family":"Alaboudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad A","family":"Alkhathran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talal","family":"Abu Suliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmohsen F","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maymunah I","family":"Ezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghadir J","family":"Almajid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab H","family":"Almutleeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munira A","family":"Msawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/sjmms.sjmms_394_22","article-title":"Prevalence of type 2 diabetes mellitus in the general population of Saudi Arabia, 2000-2020: a systematic review and meta-analysis of observational studies","volume":"11","author":"Jarrar M","year":"2023","unstructured":"Jarrar M, Abusalah MA, Albaker W, et al.. Prevalence of type 2 diabetes mellitus in the general population of Saudi Arabia, 2000-2020: a systematic review and meta-analysis of observational studies. Saudi J Med Med Sci. 2023, 11:1-10. 10.4103\/sjmms.sjmms_394_22","journal-title":"Saudi J Med Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0830","article-title":"Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. adult patients with type 1 diabetes: a real-world study","volume":"42","author":"Pettus JH","year":"2019","unstructured":"Pettus JH, Zhou FL, Shepherd L, et al.. Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. adult patients with type 1 diabetes: a real-world study. Diabetes Care. 2019, 42:2220-7. 10.2337\/dc19-0830","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1789","article-title":"A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin","volume":"30","author":"Gangji AS","year":"2007","unstructured":"Gangji AS, Cukierman T, Gerstein HC, Goldsmith CH, Clase CM. A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin. Diabetes Care. 2007, 30:389-94. 10.2337\/dc06-1789","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108522","article-title":"Incidence and prevalence of hypoglycaemia in type 1 and type 2 diabetes individuals: a systematic review and meta-analysis","volume":"170","author":"Alwafi H","year":"2020","unstructured":"Alwafi H, Alsharif AA, Wei L, et al.. Incidence and prevalence of hypoglycaemia in type 1 and type 2 diabetes individuals: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2020, 170:10.1016\/j.diabres.2020.108522","journal-title":"Diabetes Res Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.24911\/IJMDC.51-1609148506","article-title":"The incidence of hypoglycemia and its risk factors among diabetic patients in the Eastern Province of Saudi Arabia","volume":"5","author":"Elshebiny AM","year":"2021","unstructured":"Elshebiny AM, Alali HA, Alamer ZM, Alsultan YK, Alkhalaf HE, Alkishi AM, Alsuwaylih MA. The incidence of hypoglycemia and its risk factors among diabetic patients in the Eastern Province of Saudi Arabia. IJMDC. 2021, 5:614-21. 10.24911\/IJMDC.51-1609148506","journal-title":"IJMDC"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2010.05.003","article-title":"Hypoglycemia in type 1 diabetes mellitus","volume":"39","author":"Cryer PE","year":"2010","unstructured":"Cryer PE. Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin North Am. 2010, 39:641-54. 10.1016\/j.ecl.2010.05.003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2017.10.010","article-title":"Hypoglycemia","volume":"42","author":"Yale JF","year":"2018","unstructured":"Yale JF, Paty B, Senior PA. Hypoglycemia. Can J Diabetes. 2018, 42:104-8. 10.1016\/j.jcjd.2017.10.010","journal-title":"Can J Diabetes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i12.2036","article-title":"Hypoglycemia in diabetes: an update on pathophysiology, treatment, and prevention","volume":"12","author":"Nakhleh A","year":"2021","unstructured":"Nakhleh A, Shehadeh N. Hypoglycemia in diabetes: an update on pathophysiology, treatment, and prevention. World J Diabetes. 2021, 12:2036-49. 10.4239\/wjd.v12.i12.2036","journal-title":"World J Diabetes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1997.273.3.E488","article-title":"Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery","volume":"273","author":"Holste LC","year":"1997","unstructured":"Holste LC, Connolly CC, Moore MC, Neal DW, Cherrington AD. Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery. Am J Physiol. 1997, 273:488-96. 10.1152\/ajpendo.1997.273.3.E488","journal-title":"Am J Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-014-0665-0","article-title":"Glucagon for hypoglycemic episodes in insulin-treated diabetic patients: a systematic review and meta-analysis with a comparison of glucagon with dextrose and of different glucagon formulations","volume":"52","author":"Boido A","year":"2015","unstructured":"Boido A, Ceriani V, Pontiroli AE. Glucagon for hypoglycemic episodes in insulin-treated diabetic patients: a systematic review and meta-analysis with a comparison of glucagon with dextrose and of different glucagon formulations. Acta Diabetol. 2015, 52:405-12. 10.1007\/s00592-014-0665-0","journal-title":"Acta Diabetol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01483-y","article-title":"Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis","volume":"57","author":"Pontiroli AE","year":"2020","unstructured":"Pontiroli AE, Tagliabue E. Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis. Acta Diabetol. 2020, 57:743-9. 10.1007\/s00592-020-01483-y","journal-title":"Acta Diabetol"},{"key":"ref12","article-title":"Nasal drug delivery in EMS: reducing needlestick risk","volume":"28","author":"Wolfe T","year":"2003","unstructured":"Wolfe T, Barton E. Nasal drug delivery in EMS: reducing needlestick risk. JEMS. 2003, 28:52-63.","journal-title":"JEMS"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S006","article-title":"Glycemic targets: standards of medical care in diabetes - 2021","volume":"44","year":"2021","unstructured":"Glycemic targets. standards of medical care in diabetes - 2021. Diabetes Care. 2021, 44:73-84. 10.2337\/dc21-S006","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1055\/a-0741-6763","article-title":"Hypoglycemia and glucagon utilization in insulin-treated diabetic patients","volume":"128","author":"Vilovic M","year":"2020","unstructured":"Vilovic M, Kurir TT, Novak A, et al.. Hypoglycemia and glucagon utilization in insulin-treated diabetic patients. Exp Clin Endocrinol Diabetes. 2020, 128:493-8. 10.1055\/a-0741-6763","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/0145721707312400","article-title":"Glucagon as a treatment of severe hypoglycemia","volume":"34","author":"Pearson T","year":"2008","unstructured":"Pearson T. Glucagon as a treatment of severe hypoglycemia. Diabetes Educ. 2008, 34:128-34. 10.1177\/0145721707312400","journal-title":"Diabetes Educ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40808-020-00802-0","article-title":"Analyzing the geomorphometric characteristics of semiarid urban watersheds based on an integrated GIS-based approach","volume":"6","author":"Radwan F","year":"2020","unstructured":"Radwan F, Alazba P, Mossad A. Analyzing the geomorphometric characteristics of semiarid urban watersheds based on an integrated GIS-based approach. Model Earth Syst Environ. 2020, 6:1913-32. 10.1007\/s40808-020-00802-0","journal-title":"Model Earth Syst Environ"},{"key":"ref17","article-title":"Knowledge, attitude, and practice level of using diabetes medication to lose weight for non-diabetic patients","volume":"13","author":"AlGamdi K","year":"2022","unstructured":"AlGamdi K, AlQahtani F, AlShangiti A, et al.. Knowledge, attitude, and practice level of using diabetes medication to lose weight for non-diabetic patients. Arch Pharm Pract. 2022, 13:55-62.","journal-title":"Arch Pharm Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0257","article-title":"A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison","volume":"44","author":"Addala A","year":"2021","unstructured":"Addala A, Auzanneau M, Miller K, et al.. A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison. Diabetes Care. 2021, 44:133-40. 10.2337\/dc20-0257","journal-title":"Diabetes Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0145721719855931","article-title":"Diabetes education impact on hypoglycemia outcomes: a systematic review of evidence and gaps in the literature","volume":"45","author":"LaManna J","year":"2019","unstructured":"LaManna J, Litchman ML, Dickinson JK, et al.. Diabetes education impact on hypoglycemia outcomes: a systematic review of evidence and gaps in the literature. Diabetes Educ. 2019, 45:349-69. 10.1177\/0145721719855931","journal-title":"Diabetes Educ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2021.2020.0191","article-title":"An evaluation of glucagon injection anxiety and its association with the fear of hypoglycemia among the parents of children with type 1 diabetes","volume":"13","author":"Murado\u011flu S","year":"2021","unstructured":"Murado\u011flu S, Mutlu GY, G\u00f6k\u00e7e T, Can E, Hatun \u015e. An evaluation of glucagon injection anxiety and its association with the fear of hypoglycemia among the parents of children with type 1 diabetes. J Clin Res Pediatr Endocrinol. 2021, 13:285-92. 10.4274\/jcrpe.galenos.2021.2020.0191","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13278","article-title":"Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting","volume":"20","author":"Seaquist ER","year":"2018","unstructured":"Seaquist ER, Dulude H, Zhang XM, et al.. Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting. Diabetes Obes Metab. 2018, 20:1316-20. 10.1111\/dom.13278","journal-title":"Diabetes Obes Metab"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-05962-z","article-title":"Socioeconomic aspects of incretin-based therapy","volume":"66","author":"Karagiannis T","year":"2023","unstructured":"Karagiannis T, Bekiari E, Tsapas A. Socioeconomic aspects of incretin-based therapy. Diabetologia. 2023, 66:1859-68. 10.1007\/s00125-023-05962-z","journal-title":"Diabetologia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.4182","article-title":"Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US","volume":"2","author":"Eberly LA","year":"2021","unstructured":"Eberly LA, Yang L, Essien UR, et al.. Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US. JAMA Health Forum. 2021, 2:10.1001\/jamahealthforum.2021.4182","journal-title":"JAMA Health Forum"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317653","article-title":"Magnitude, risk factors and economic impacts of diabetic emergencies in developing countries: a systematic review","volume":"20","author":"Haile HK","year":"2025","unstructured":"Haile HK, Fenta TG. Magnitude, risk factors and economic impacts of diabetic emergencies in developing countries: a systematic review. PLoS One. 2025, 20:10.1371\/journal.pone.0317653","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.15226\/2374-6890\/3\/5\/00163","article-title":"Confronting complacency in the face of calamity: mobilizing for the home front war against diabetes","volume":"3","author":"Schillinger D","year":"2016","unstructured":"Schillinger D. Confronting complacency in the face of calamity: mobilizing for the home front war against diabetes. J Endocrinol Diabetes. 2016, 3:10.15226\/2374-6890\/3\/5\/00163","journal-title":"J Endocrinol Diabetes"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15084","article-title":"'Didn't see the need': misperceptions about glucagon from the perspectives of people with diabetes and their caregivers","volume":"40","author":"Stuckey HL","year":"2023","unstructured":"Stuckey HL, Desai U, Mitchell BD, Pearson TL. 'Didn't see the need': misperceptions about glucagon from the perspectives of people with diabetes and their caregivers. Diabet Med. 2023, 40:10.1111\/dme.15084","journal-title":"Diabet Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae163.767","article-title":"7604 examining disparities in diabetes control and complications: a comparative study of type 2 diabetes mellitus patients in rural and urban Saudi Arabia","volume":"8","author":"Alqifari SF","year":"2024","unstructured":"Alqifari SF, Alkomi O, Amirthalingam P, et al.. 7604 examining disparities in diabetes control and complications: a comparative study of type 2 diabetes mellitus patients in rural and urban Saudi Arabia. J Endocr Soc. 2024, 8:10.1210\/jendso\/bvae163.767","journal-title":"J Endocr Soc"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/1179556517748913","article-title":"Hypoglycemia: when to treat?","volume":"11","author":"Kallem VR","year":"2017","unstructured":"Kallem VR, Pandita A, Gupta G. Hypoglycemia: when to treat?. Clin Med Insights Pediatr. 2017, 11:10.1177\/1179556517748913","journal-title":"Clin Med Insights Pediatr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1258-7","article-title":"Diabetes and disasters: recent studies and resources for preparedness","volume":"19","author":"Allweiss P","year":"2019","unstructured":"Allweiss P. Diabetes and disasters: recent studies and resources for preparedness. Curr Diab Rep. 2019, 19:10.1007\/s11892-019-1258-7","journal-title":"Curr Diab Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15470","article-title":"Technology and health inequities in diabetes care: how do we widen access to underserved populations and utilize technology to improve outcomes for all?","volume":"26","author":"Ebekozien O","year":"2024","unstructured":"Ebekozien O, Fantasia K, Farrokhi F, Sabharwal A, Kerr D. Technology and health inequities in diabetes care: how do we widen access to underserved populations and utilize technology to improve outcomes for all?. Diabetes Obes Metab. 2024, 26:3-13. 10.1111\/dom.15470","journal-title":"Diabetes Obes Metab"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13491","article-title":"Trends in clinical characteristics, medication use, and glycemic control in insulin-treated patients with type 1 and type 2 diabetes in Finland in 2012-2019: nationwide real-world evidence study","volume":"16","author":"Niskanen L","year":"2024","unstructured":"Niskanen L, Hannula M, Kysenius K, Kaijala S, Lassenius MI, Valle TT. Trends in clinical characteristics, medication use, and glycemic control in insulin-treated patients with type 1 and type 2 diabetes in Finland in 2012-2019: nationwide real-world evidence study. J Diabetes. 2024, 16:10.1111\/1753-0407.13491","journal-title":"J Diabetes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/362297-assessing-the-knowledge-of-diabetic-patients-about-glucagon-use-in-hypoglycemia-a-cross-sectional-study-in-riyadh-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T10:27:13Z","timestamp":1748514433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/362297-assessing-the-knowledge-of-diabetic-patients-about-glucagon-use-in-hypoglycemia-a-cross-sectional-study-in-riyadh-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.85017","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}